Positive case studies have been received from among the 1500 pilot study participants. Additional prospective studies are ongoing. GenoTrim can be purchased through Salugen's distribution partner DNA Services of America or at http://www.GenoTrim.com .
GenoTrim is a DNA-customized nutritional solution for weight management. Based upon an analysis of five important genes effecting weight, GenoTrim ingredients and dosages are genetically-guided to address the underlying genetic factors involved in hormones and metabolism that Harvard Medical Experts suggest influence 70% to 80% of overweight cases. By addressing genetic factors that make individuals prone to weight problems, GenoTrim has demonstrated in studies to help reduce weight, appetite, sugar cravings, snacking, and late-night eating, as well as help support improved sleep, mood, and energy levels which results in sustainable weight loss. For more information on GenoTrim, please visit http://www.genotrim.com.
Salugen, Inc., a leading personalized health and wellness company,
engages in the discovery, development and commercialization of
patent-protected genetic tests and companion DNA-customized therapeutics
worldwide. With over 30 years of research conducted on the genetic causes
and pharmacology of many healthcare concerns, Salugen is a pioneer and
leader in delivering personalized medicine. Currently, the Company
commercializes nutrigenomic technologies where genetic analysis guides the
formulation and delivery of nutritional solutions that are customized to
the individual. The company has headquarters in San Diego, CA, with its
high-complexity CLIA-certified laboratory services in Los Angeles, CA. For
Copyright©2007 PR Newswire.
All rights reserved